T cell tolerance induced by cross-reactive TCR ligands can be broken by superagonist resulting in anti-inflammatory T cell cytokine production

Journal of Immunology

Volumn 175, Issue 3, 2005, Pages 1491-1497

  Illés, Zsolt ^a   Waldner, Hanspeter ^a,b   Reddy, Jayagopala ^a   Bettelli, Estelle ^a   Nicholson, Lindsay B ^a,c   Kuchroo, Vijay K ^a  

^a Brigham and Women's Hospital Center for Neurologic Diseases   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; AUTOANTIGEN; CYTOKINE; IMMUNOSTIMULATING AGENT; INTERLEUKIN 1; INTERLEUKIN 10; L144 PEPTIDE; LIGAND; LIGAND Q144; PEPTIDE; PROTEOLIPID PROTEIN; PROTEOLIPID PROTEIN[139-151]; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ADOLESCENT; ANIMAL CELL; ANTIGEN BINDING; ANTIINFLAMMATORY ACTIVITY; ARTICLE; AUTOIMMUNITY; BINDING AFFINITY; CONTROLLED STUDY; CROSS REACTION; CYTOKINE PRODUCTION; FEMALE; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH2 CELL; TRANSGENIC MOUSE;

EID: 22544474149     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.3.1491     Document Type: Article

References (50)

1. Anderson, A. C., L. B. Nicholson, K. L. Legge, V. Turchin, H. Zaghouani, and V. K. Kuchroo. 2000. High frequency of autoreactive myelin proteolipid protein-specific T cells in the periphery of naive mice: mechanisms of selection of the self-reactive repertoire. J. Exp. Med. 191: 761-770.
2. Klein, L., M. Klugmann, K. A. Nave, V. K. Tuohy, and B. Kyewski. 2000. Shaping of the autoreactive T-cell repertoire by a splice variant of self protein expressed in thymic epithelial cells. Nat. Med. 6: 56-61.
3. Liston, A., S. Lesage, J. Wilson, L. Peltonen, and C. C. Goodnow. 2003. Aire regulates negative selection of organ-specific T cells. Nat. Immunol. 4: 350-354.
4. Bevan, M. J. 1997. In thymic selection, peptide diversity gives and takes away. Immunity 7: 175-178.
5. Goldrath, A. W., and M. J. Bevan. 1999. Selecting and maintaining a diverse T-cell repertoire. Nature 402: 255-262.
6. Kuchroo, V. K., A. C. Anderson, H. Waldner, M. Munder, E. Bettelli, and L. B. Nicholson. 2002. T cell response in experimental autoimmune encephalomyelitis (EAE): role of self and cross-reactive antigens in shaping, tuning and regulating the autopathogenic T cell repertoire. Annu. Rev. Immunol. 20: 101-123.
7. Ohashi, P. S., S. Oehen, K. Buerki, H. Pircher, C. T. Ohashi, B. Odermatt, B. Malissen, R. M. Zinkernagel, and H. Hengartner. 1991. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 65: 305-317.
8. Oldstone, M. B., M, Nerenberg, P, Southern, J. Price, and H. Lewicki. 1991. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell 65: 319-331.
9. Schonrich, G., U. Kalinke, F. Momburg, M. Malissen, A. M. Schmitt-Verhulst, B. Malissen, G. J. Hammerling, and B. Arnold. 1991. Down-regulation of Tcell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance induction. Cell 65: 293-304.
10. Zhang, L., W. Fung-Leung, and R. G. Miller. 1995. Down-regulation of CD8 on mature antigen-reactive T cells as a mechanism of peripheral tolerance. J. Immunol. 155: 3464-3471.
11. Wang, R., Y. Wang-Zhu, and H. Grey. 2002, Interactions between double positive thymocytes and high-affinity ligands presented by cortical epithelial cells generate double negative thymocytes with T cell regulatory activity. Proc. Natl. Acad. Sci. USA 99: 2181-2186.
12. Jones, L. A., L. T. Chin, D. L. Longo, and A. M. Kruisbeek. 1990. Peripheral clonal elimination of functional T cells. Science 250: 1726-1729.
13. + T cells. Int. Immunol. 4: 599-610.
14. + antigen-specific T cells after in vivo exposure to male antigen. J. Immunol. 148: 3740-3745.
15. Jenkins, M. K., and R. H. Schwanz. 1987. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J. Exp. Med. 165: 302-319.
16. Mueller, D. L., M. K. ienkins, and R. H. Schwanz. 1989. Clonal expansion versus functional clonal inactivation: a costimulatory signaling pathway determines the outcome of T cell antigen receptor occupancy. Annu. Rev. Immunol. 7: 445-480.
17. Schwanz, R. H. 1990. A cell culture model for T lymphocyte clonal anergy. Science 248: 1349-1356.
18. Rocha, B., C. Tanchot, and H. von Boehmer. 1993. Clonal anergy blocks in vivo growth of mature T cells and can be reversed in the absence of antigen. J. Exp. Med. 177: 1517-1521.
19. + T cells specific for a pancreatic β cell neoantigen. Immunity 1: 573-585.
20. Falb, D., T. J. Briner, G. H. Sunshine, C. R. Bourque, M. Luqman, M. L. Gefter, and T. Kamradt. 1996. Peripheral tolerance in T cell receptor-transgenic mice: evidence for T cell anergy. [Published erratum appears in 1996 Eur. J. Immunol. 26: 966.] Eur. J. Immunol. 26: 130-135.
21. Akkaraju, S., W. Y. Ho, D. Leong, K. Canaan, M. M. Davis, and C. C. Goodnow. 1997. A range of CD4 T cell tolerance: partial activation to organ-specific antigen allows nondestructive thyroiditis or insuiitis. Immunity 7: 255-271.
22. + T cells by staphylococcal enterotoxin B. J. Exp. Med. 172: 1091-1100.
23. Blackman, M. A., T. H. Finkel, J. Kappler, J. Cambier, and P. Marrack. 1991. Altered antigen receptor signaling in anergic T cells from self-tolerant T-cell receptor B-chain transgenic mice. Proc. Natl. Acad. Sci. USA 88: 6682-6686.
24. Migita, K., and A. Ochi. 1993. The fate of anergic T cells in vivo. J. Immunol. 150: 763-770.
25. Miethke, T., C. Wahl, H. Gaus, K. Heeg, and H. Wagner. 1994. Exogeneous superarttigens acutely trigger distinct levels of peripheral T cell tolerance/immunosuppressiori: dose-response relationship. Eur. J. Immunol. 24: 1893-1902.
26. Perkins, D. L., Y. Wang, S. Ho, G. R. Wiens, J. G. Seidman, and I. J. Rimm. 1993. Superantigen-induced peripheral tolerance inhibits T cell responses to immunogenic peptides in TCR (β-chain) transgenic mice. J. Immunol. 150: 4284-4291.
27. Bar-Or, A., E. M. Oliveira, D. E. Anderson, and D. A. Hafler. 1999. Molecular pathogenesis of multiple sclerosis, J. Neuroimmunol. 100: 252-259.
28. Olson, J.K., J. L. Croxford, M. A. Calenoff, M. C. Dal Canto, and S. D. Miller. 2001. A virus-induced molecular mimicry model of multiple sclerosis. J. Clin. Invest. 108: 311-318.
29. Munder, M., E. Bettelli, L. Monney, J. M. Slavik, L. B. Nicholson, and V. K. Kuchroo. 2002. Reduced self-reactivity of an autoreactive T cell after activation with cross-reactive non-self-ligand. J. Exp. Med. 196: 1151-1162.
30. Nicholson, L. B., H. Waldner, A. M. Carrizosa, A. Sette, M. Collins, and V. K. Kuchroo. 1998. Heteroclitic proliferative responses and changes in cytokine profile induced by altered peptides: implications for autoimmunity. Proc. Natl. Acad. Sci. USA 95: 264-269.
31. Kearney, E., K. Pape, D. Loh, and M. Jenkins. 1994. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1: 327-339.
32. Vidovic, D., and P. Matzinger. 1988. Unresponsiveness to a foreign antigen can be caused by self-tolerance. Nature 336: 222-225.
33. Targoni, O. S., and P. V. Lehmann. 1998. Endogeneous myelin basic protein inactivates the high avidity T cell repertoire. J. Exp. Med. 187: 2055-2063.
34. Poplonski, L., B. Vukusic, J. Pawling, S. Clapoff, J. Roder, N. Hozumi, and J. Wither. 1996. Tolerance is overcome in beef insulin-transgenic mice by activation of low-affinity autoreactive T cells. Eur. J. Immunol. 26: 601-609.
35. Theobald, M., J. Biggs, J. Hernandez, J. Lustgarten, C. Labadie, and L. A. Sherman. 1997. Tolerance to p53 by A2.1-restricted cytotoxic T lymphocytes. J. Exp. Med. 185: 833-841.
36. Zügel, U., R. Wang, G. Shih, A. Sette, J. Alexander, and H. M. Grey. 1998. Termination of peripheral tolerance to a T cell epitope by heteroclitic antigen analogues. J. Immunol. 161: 1705-1709.
37. Wang, R., Y. Wang-Zhu, C. R. Gabaglia, K. Kimachi, and H. M. Grey. 1999. The stimulation of low-affinity, nontolerized clones by heteroclitic antigen analogues causes breaking of tolerance established to an immunodominant T cell epitope. J. Exp. Med. 190: 983-994.
38. Pearson, C. I., W. van Ewijk, and H. O. McDewitt. 1997. Induction of apoptosis and T helper 2 (Th2) responses correlates with peptide affinity for the major histocompatibility complex in self-reactive T cell receptor transgenic mice. J. Exp. Med. 185: 583-599.
39. Buer, J., A. Lanoue, A. Franzke, C. Garcia, H. von Boehmer, and A. Sarukhan. 1998, Interleukin 10 secretion and impaired effector function of major histocompatibility complex class II-restricted T cells anergized in vivo. J. Exp. Med. 187: 177-183.
40. Sundstedt, A., I. Höidén, A. Rosendahl, T. Kalland, N. van Rooijen, and M. Dohlsten. 1997. Immunoregulatoty role of IL-10 during superantigen-induced hyporesponsiveness in vivo. J. Immunol. 158: 180-186.
41. Bachetta, R., M. Bigler, J. L. Touraine, R. Parkman, P. A. Tovo, J. Abrams, and M. G. Roncarolo. 1994. high levels of IL-10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoetic stem cells. J. Exp. Med. 179: 493-502.
42. Evavold, B. D., and P. M. Allen. 1991. Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science 252: 1308-1310.
43. Hemmer, B., I. Stefanova, M. Vergelli, R. N. Germain, and R. Martin. 1998. Relationships among TCR ligand potency, thresholds for effector function elicitation, and the quality of early signaling events in human T cells. J. Immunol. 160: 5807-5814.
44. + T helper cell phenotype development in a T cell receptor-αβ-transgenic model. J. Exp. Med. 182: 1579-1584.
45. + T cells. J. Exp. Med. 182: 1591-1596.
46. + T cells by antigenic peptides altered for TCR binding. J. Immunol. 158: 4237-4244.
47. + T cells exhibit distinct expression patterns of cytokines and cell surface molecules on their primary responses to varying doses of antigen. J. Immunol. 168: 3242-3250.
48. Mathisen, P. M., M. Yu, J. M. Johnson, J. A. Drazba, and V. Tuohy. 1997. Treatment of experimental autoimmune encephalomyelitis with genetically modified memory T cells. J. Exp. Med. 186: 159-164.
49. + T cell subset inhibits antigen specific T cell responses and prevents colitis. Nature 389: 737-742.
50. Bettelli, E., M. P. Das, E. D. Howard, H. L. Weiner, R. A. Sobel, and V. K. Kuchroo. 1998. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J. Immunol. 161:3299-3306.